Langzeitergebnisse nach Herztransplantation

Summary Long-term survival after heart transplantation has continuously improved for the last centuries. Improvement of donor and recipient selection, better perioperative management and advances in immunosuppression have substationally improved outcome. Survival, however, is still influenced by multiple factors. Beside the prevention of rejection, control of the classical cardiovascular risk factors is crucial. Moreover, the use of immunosuppressive agents should be individualised and complication as tumours and infections should be taken into account. In as much new immunosuppressive medications will impact on the long-term survival in the future has to be shown.